Session

PP 05 IBD (Posters)

DERMAL LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY IN PATIENTS WITH INFLAMMATORY BOEWL DISEASES: INSIGHTS FROM A IBD TERTIARY CENTER IN POLAND - A SINGLE-CENTER, RETROSPECTIVE STUDY
DERMAL LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY IN PATIENTS WITH INFLAMMATORY BOEWL DISEASES: INSIGHTS FROM A IBD TERTIARY CENTER IN POLAND - A SINGLE-CENTER, RETROSPECTIVE STUDY

FAECAL CALPROTECTIN IS A NON-SPECIFIC MARKER OF INFLAMMATION IN ADULTS OVER THE AGE OF 50
FAECAL CALPROTECTIN IS A NON-SPECIFIC MARKER OF INFLAMMATION IN ADULTS OVER THE AGE OF 50

BIOMARKER OF CORTICOSTEROID THERAPY FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
BIOMARKER OF CORTICOSTEROID THERAPY FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

REAL-WORLD STUDY ON VEDOLIZUMAB EFFICACY AND SAFETY AFTER THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS
REAL-WORLD STUDY ON VEDOLIZUMAB EFFICACY AND SAFETY AFTER THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS

CORRELATIONS BETWEEN THE INFLAMMATORY BURDEN AND QUALITY OF LIFE IN A PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
CORRELATIONS BETWEEN THE INFLAMMATORY BURDEN AND QUALITY OF LIFE IN A PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

EFFECTIVENESS AND SAFETY OF A SECOND-LINE RESCUE THERAPY IN HOSPITALISED PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS STEROID-REFRACTORY AFTER FAILING INFLIXIMAB OR CICLOSPORIN (REASUC STUDY)
EFFECTIVENESS AND SAFETY OF A SECOND-LINE RESCUE THERAPY IN HOSPITALISED PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS STEROID-REFRACTORY AFTER FAILING INFLIXIMAB OR CICLOSPORIN (REASUC STUDY)

LATE PREGNANCY INDUCES GUT MICROBIOME CHANGES IN MICE WITH EPITHELIAL KNOCKOUT OF THE CROHN’S DISEASE RISK GENE ATG16L1
LATE PREGNANCY INDUCES GUT MICROBIOME CHANGES IN MICE WITH EPITHELIAL KNOCKOUT OF THE CROHN’S DISEASE RISK GENE ATG16L1

PHOSPHOGLYCERATE DEHYDROGENASE PLAYS A VITAL ROLE IN ER-STRESS-RELATED INTESTINAL INFLAMMATION
PHOSPHOGLYCERATE DEHYDROGENASE PLAYS A VITAL ROLE IN ER-STRESS-RELATED INTESTINAL INFLAMMATION

REAL WORLD ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS: A RETROSPECTIVE COHORT STUDY
REAL WORLD ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS: A RETROSPECTIVE COHORT STUDY

REMOVAL OF DIETARY FIBER INCREASES THE SEVERITY AND DELAYS THE RECOVERY OF DSS-INDUCED COLITIS IN MICE, INDEPENDENT OF SHORT-CHAIN FATTY ACID RECEPTOR SIGNALING
REMOVAL OF DIETARY FIBER INCREASES THE SEVERITY AND DELAYS THE RECOVERY OF DSS-INDUCED COLITIS IN MICE, INDEPENDENT OF SHORT-CHAIN FATTY ACID RECEPTOR SIGNALING

IMPACT OF FILGOTINIB ON INDIVIDUAL INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE ITEMS: POST HOC ANALYSES FROM SELECTION
IMPACT OF FILGOTINIB ON INDIVIDUAL INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE ITEMS: POST HOC ANALYSES FROM SELECTION

​EFFECTIVENESS OF EXTENDED MESENTERIC EXCISION IN PREVENTING POSTOPERATIVE CROHN’S DISEASE RECURRENCE: SYSTEMATIC REVIEW AND META-ANALYSIS
​EFFECTIVENESS OF EXTENDED MESENTERIC EXCISION IN PREVENTING POSTOPERATIVE CROHN’S DISEASE RECURRENCE: SYSTEMATIC REVIEW AND META-ANALYSIS

PROTEOMIC CHARACTERIZATION OF SERUM EXTRACELLULAR VESICLES FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PROTEOMIC CHARACTERIZATION OF SERUM EXTRACELLULAR VESICLES FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE

THE EFFECT OF PROTON-PUMP INHIBITORS ON DISEASE OUTCOME IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY
THE EFFECT OF PROTON-PUMP INHIBITORS ON DISEASE OUTCOME IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY

REAL-LIFE VS TRIAL ACCESS TO BIOLOGICAL THERAPY DIFFERENCES: A 2019-2020 EXPERIENCE IN AN ITALIAN TERTIARY IBD CENTER
REAL-LIFE VS TRIAL ACCESS TO BIOLOGICAL THERAPY DIFFERENCES: A 2019-2020 EXPERIENCE IN AN ITALIAN TERTIARY IBD CENTER

PREDICTING CLOSTRIDIOIDES DIFFICILE INFECTION IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO GUT MICROBIAL COMPOSITION AND SHORT CHAIN FATTY ACIDS PRODUCTION
PREDICTING CLOSTRIDIOIDES DIFFICILE INFECTION IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO GUT MICROBIAL COMPOSITION AND SHORT CHAIN FATTY ACIDS PRODUCTION

REAL-WORLD EVIDENCE DATA WAREHOUSE FOR POOLED ANALYSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN GERMANY: THE “UMBRELLA-IBD REGISTRY” OF THE COMPETENCE NETWORK IBD
REAL-WORLD EVIDENCE DATA WAREHOUSE FOR POOLED ANALYSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN GERMANY: THE “UMBRELLA-IBD REGISTRY” OF THE COMPETENCE NETWORK IBD

PREDICTORS OF ENDOSCOPIC AND HISTOLOGIC RESPONSE AFTER FIRST-LINE BIOLOGIC THERAPY IN ULCERATIVE COLITIS
PREDICTORS OF ENDOSCOPIC AND HISTOLOGIC RESPONSE AFTER FIRST-LINE BIOLOGIC THERAPY IN ULCERATIVE COLITIS

THE DEPENDENCE OF THE CONCENTRATION OF TYPE 2 GLYCOPROTEIN ON THE CONCENTRATION OF ZONULIN IN CROHN'S DISEASE DURING REMISSION OF THE DISEASE
THE DEPENDENCE OF THE CONCENTRATION OF TYPE 2 GLYCOPROTEIN ON THE CONCENTRATION OF ZONULIN IN CROHN'S DISEASE DURING REMISSION OF THE DISEASE

ACUTE SEVERE ULCERATIVE COLITIS: ULCERATIVE COLITIS VERSUS CROHN’S DISEASE
ACUTE SEVERE ULCERATIVE COLITIS: ULCERATIVE COLITIS VERSUS CROHN’S DISEASE

Item 601 - 620 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
31
32 33 34 35 36 37 38 39 40 41 42